Sarita Kapila
Stock Analyst at Morgan Stanley
(0.69)
# 4,001
Out of 4,574 analysts
57
Total ratings
38.2%
Success rate
-5.4%
Average return
Main Sectors:
Stocks Rated by Sarita Kapila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,500p → 15,300p | 12,670p | +20.76% | 12 | Jul 16, 2026 | |
| SNY Sanofi | Maintained: Hold | $52 → $49 | $43.35 | +13.03% | 4 | Jul 8, 2026 | |
| SWX: ROP Roche Holding AG | Upgraded: Hold | CHF 295.00 | CHF 355.10 | -16.92% | 10 | Apr 24, 2026 | |
| RHHBY Roche Holding AG | Maintained: Sell | $39 → $46 | $54.70 | -15.90% | 2 | Apr 7, 2026 | |
| LON: 0NZT UCB SA | Downgraded: Hold | €260.00 | €240.88 | +7.94% | 6 | Mar 6, 2026 | |
| LON: GSK GSK plc | Maintained: Sell | 1,600p → 1,700p | 1,920p | -11.44% | 8 | Mar 2, 2026 | |
| EPA: SAN Sanofi | Upgraded: Buy | €100.00 | €76.03 | +31.53% | 1 | Sep 8, 2025 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Hold | kr 253.10 → kr 257.88 | kr 457.40 | n/a | 2 | May 4, 2023 | |
| GRFS Grifols | Maintained: Buy | $16 → $18 | $7.58 | n/a | 2 | Feb 8, 2023 | |
| BME: GRF Grifols, S.A. | Maintained: Buy | €14.00 → €16.00 | €9.66 | n/a | 6 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $36 | $45.01 | n/a | 4 | Nov 16, 2022 |
AstraZeneca PLC
Jul 16, 2026
Maintained: Buy
Price Target: 16,500p → 15,300p
Current: 12,670p
Upside: +20.76%
Sanofi
Jul 8, 2026
Maintained: Hold
Price Target: $52 → $49
Current: $43.35
Upside: +13.03%
Roche Holding AG
Apr 24, 2026
Upgraded: Hold
Price Target: CHF 295.00
Current: CHF 355.10
Upside: -16.92%
Roche Holding AG
Apr 7, 2026
Maintained: Sell
Price Target: $39 → $46
Current: $54.70
Upside: -15.90%
UCB SA
Mar 6, 2026
Downgraded: Hold
Price Target: €260.00
Current: €240.88
Upside: +7.94%
GSK plc
Mar 2, 2026
Maintained: Sell
Price Target: 1,600p → 1,700p
Current: 1,920p
Upside: -11.44%
Sanofi
Sep 8, 2025
Upgraded: Buy
Price Target: €100.00
Current: €76.03
Upside: +31.53%
Swedish Orphan Biovitrum AB (publ)
May 4, 2023
Maintained: Hold
Price Target: kr 253.10 → kr 257.88
Current: kr 457.40
Upside: n/a
Grifols
Feb 8, 2023
Maintained: Buy
Price Target: $16 → $18
Current: $7.58
Upside: n/a
Grifols, S.A.
Feb 8, 2023
Maintained: Buy
Price Target: €14.00 → €16.00
Current: €9.66
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $36
Current: $45.01
Upside: n/a